This inventor holds 1 USPTO granted patent. Top assignee: Rbs Pharma (Roger Bellon Schoum) S.p.a.. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Alberta Sosio - Innovator in Imidazopyridine Compounds
Alberta Sosio is a notable inventor based in Milan, Italy. She has made significant contributions to the field of chemistry, particularly in the development of new imidazopyridine derivatives. Her work has led to the creation of innovative compounds that hold potential for various applications.
Latest Patents
Alberta Sosio holds a patent for imidazopyridine compounds. The patent describes new imidazopyridine derivatives characterized by a specific formula, wherein R can represent a hydrogen atom, an alkyl radical of 1 to 3 carbon atoms, a methoxy group, or a halogen atom. This patent showcases her expertise and creativity in the field of chemical innovation. She has 1 patent to her name.
Career Highlights
Alberta Sosio is currently employed at RBS Pharma (Roger Bellon Schoum) S.p.a., where she continues to push the boundaries of pharmaceutical research. Her work at RBS Pharma has allowed her to collaborate with other talented professionals in the industry, further enhancing her contributions to the field.
Collaborations
Some of her notable coworkers include Piero Bellani and Gaetano Clavenna. Their collaborative efforts have likely played a role in advancing their shared goals in pharmaceutical innovation.
Conclusion
Alberta Sosio is a pioneering inventor whose work in imidazopyridine compounds exemplifies her commitment to advancing chemical research. Her contributions are significant in the realm of pharmaceuticals, and her innovative spirit continues to inspire others in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile